v3.26.1
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2025
Revenue Recognition [Abstract]  
Schedule of Revenue by Product Category

The following table presents the Company’s revenue by product category for the years ended December 31, 2025, and 2024:

 

   For the Years Ended
December 31,
 
   2025   2024 
Training  $1,125,521   $809,654 
Product supplies   2,024,573    1,748,961 
Equipment   75,835    177,225 
Patient procedures   1,874,386    1,371,654 
Total revenue  $5,100,315   $4,107,494 
Schedule of Revenues, Cost of Revenues, Gross Profits, Assets and Net Loss

Listed below are the revenues, cost of revenues, gross profits, assets and net loss by Company:

 

   For the Year Ended 
   December 31, 2025 
   Global Stem   Meso     
   Cells Group   Numismatics   Total 
Revenue  $5,100,315   $
-
   $5,100,315 
Cost of revenue   2,289,537    
-
    2,289,537 
Gross profit  $2,810,778   $
-
   $2,810,779 
Gross Profit %   54.73%   0.00%   54.73%
                
Assets  $2,718,911   $1,769,783   $4,488,694 
Net income (loss)  $(742,221)  $(7,070,188)  $(7,812,409)